Interesting study. I hope the company adresses this publicly at some point. Possibly at the next non-calcification milestone.
Not necessarily bad news, as long as we are the best product on the market it will ultimately become the first choice for surgeons. Time will tell but it is clearly increasing in popularity.
- Forums
- ASX - By Stock
- AVR
- oral presentation- ADAPT in AV reconstruction in CHD
oral presentation- ADAPT in AV reconstruction in CHD, page-13
-
- There are more pages in this discussion • 57 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$18.31 |
Change
-0.240(1.29%) |
Mkt cap ! $351.9M |
Open | High | Low | Value | Volume |
$18.80 | $19.15 | $18.20 | $159.7K | 8.611K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 73 | $18.31 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.33 | 90 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 150 | 18.100 |
1 | 100 | 18.050 |
1 | 250 | 18.010 |
2 | 2010 | 18.000 |
1 | 55 | 17.910 |
Price($) | Vol. | No. |
---|---|---|
19.000 | 500 | 1 |
20.000 | 2950 | 4 |
20.120 | 420 | 1 |
20.200 | 309 | 1 |
20.400 | 678 | 1 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online